Latest New Zealand News

Bravura Solutions has raised its FY26 revenue and cash EBITDA guidance, reflecting robust project engagement and disciplined cost management. The company also plans increased investment in internal technology.

CAR Group Limited has announced a fully paid ordinary dividend of AUD 0.425 per share for the six months ending December 2025, accompanied by a Dividend Reinvestment Plan (DRP) with no discount.

Kalamazoo Resources has successfully closed an oversubscribed Share Purchase Plan, raising $4.1 million to fast-track drilling and development at its Ashburton Gold Project. Combined with a recent placement, the company secures $12.1 million to advance exploration and pre-feasibility studies.

Cannindah Resources has announced a two-tranche placement raising approximately $15 million and a concurrent Share Purchase Plan offering eligible shareholders the chance to invest up to $30,000 at a discounted price. The funds will support drilling and exploration at the Mt Cannindah Copper-Gold Project.

WAM Active Limited has launched a $51.4 million pro-rata entitlement offer at a 7.8% discount to the recent share price, alongside a $19.3 million institutional placement to meet strong investor demand. The capital raising aims to bolster the company’s proven Australian equity investment strategy while offering shareholders fully franked dividends on new shares.

Terragen Holdings has raised A$7 million through a strategic equity raising to fund scientific research and accelerate global commercialisation, while appointing Dr Michele Allan AO as its new Chair.

Acusensus Limited has settled its patent litigation with Redflex Traffic Systems, issuing over six million shares and paying US$6 million in cash to resolve the dispute. The agreement clears the way for Acusensus to continue its road safety technology operations unimpeded.

Imricor Medical Systems has taken a significant step toward US market entry by submitting its Advantage-MR EP Recorder/Stimulator system for FDA 510(k) clearance, aiming to enhance MRI-guided cardiac procedures.

New Age Exploration Limited has issued a prospectus to facilitate secondary trading of new options issued under a recent $3.75 million placement, offering 1,000 new options at $0.01 each. The move aims to remove trading restrictions and improve liquidity for option holders.

Manuka Resources’ subsidiary Trans-Tasman Resources has received a draft decision proposing to decline consent for its Taranaki VTM iron sands project, challenging the company’s plans to develop a critical minerals supply in New Zealand.

US1 Critical Minerals announces a bonus issue of options to shareholders and a $1.5 million placement with free attaching options, pending shareholder approval.

Epsilon Healthcare’s subsidiary, Epsilon Pharma, has signed a three-year manufacturing agreement with New Zealand’s Puro to supply medicinal cannabis products to the UK and Europe, marking a significant step in its international expansion.